论文部分内容阅读
肺炎支原体(MP)是小儿肺炎的常见致病病原体,其所致肺炎约占小儿肺炎的20%,且有逐年增高的趋势[1]。肺炎支原体肺炎(mycoplasma pneumoniae pneumonia,MPP)症状、体征多不典型,故临床上误诊率较高。阿奇霉素是新一代大环内酯类抗生素,为治疗MPP的一线用药,对患儿副作用较小,疗效肯定。痰热清为中药制剂,有抑菌、抗病毒、解热、祛痰、镇咳的作用,常配合其他药品治疗各类型肺炎[2]。笔者对120例MPP患儿采用痰热清联合阿奇霉素或单独用阿奇霉素治疗的疗效进
Mycoplasma pneumoniae (MP) is a common causative agent of childhood pneumonia, which accounts for pneumonia about 20% of children with pneumonia, and there is a trend of increasing year by year [1]. Mycoplasma pneumoniae pneumonia (mycoplasma pneumoniae pneumonia, MPP) symptoms, signs and more atypical, so the clinical diagnosis of misdiagnosis. Azithromycin is a new generation of macrolide antibiotics for the treatment of first-line MPP drugs, children with less side effects, efficacy is positive. Tanreqing traditional Chinese medicine preparation, antibacterial, anti-virus, antipyretic, expectorant, antitussive effect, often with other drugs for the treatment of various types of pneumonia [2]. The author of 120 cases of MPP with sputum heat combined with azithromycin alone or azithromycin treatment efficacy